Shevroja E - Search Results

1

DXA parameters, Trabecular Bone Score (TBS) and Bone Mineral Density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis.

Shevroja E, Cafarelli FP, Guglielmi G, Hans D. Shevroja E, et al. Endocrine. 2021 Oct;74(1):20-28. doi: 10.1007/s12020-021-02806-x. Epub 2021 Jul 10. Endocrine. 2021. PMID: 34245432 Free PMC article. Review.

2

[Use of Trabecular Bone Score as a complementary approach to DXA for fracture risk assessment in clinical practice].

Hans D, Shevroja E, Lamy O. Hans D, et al. Among authors: shevroja e. Rev Med Suisse. 2017 Apr 19;13(559):844-850. Rev Med Suisse. 2017. PMID: 28727341 French.

3

Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice.

Shevroja E, Lamy O, Kohlmeier L, Koromani F, Rivadeneira F, Hans D. Shevroja E, et al. J Clin Densitom. 2017 Jul-Sep;20(3):334-345. doi: 10.1016/j.jocd.2017.06.019. Epub 2017 Jul 19. J Clin Densitom. 2017. PMID: 28734710 Review.

4

Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.

Bilezikian JP, Hattersley G, Fitzpatrick LA, Harris AG, Shevroja E, Banks K, Leder BZ, Zanchetta JR, Hans D. Bilezikian JP, et al. Among authors: shevroja e. Osteoporos Int. 2018 Feb;29(2):323-328. doi: 10.1007/s00198-017-4304-9. Epub 2017 Nov 22. Osteoporos Int. 2018. PMID: 29167971 Free PMC article. Clinical Trial.

5

Risk-equivalent T-score adjustment for using lumbar spine trabecular bone score (TBS): the Manitoba BMD registry.

Leslie WD, Shevroja E, Johansson H, McCloskey EV, Harvey NC, Kanis JA, Hans D. Leslie WD, et al. Among authors: shevroja e. Osteoporos Int. 2018 Mar;29(3):751-758. doi: 10.1007/s00198-018-4405-0. Epub 2018 Feb 1. Osteoporos Int. 2018. PMID: 29392355 Free PMC article.

6

Review on the Utility of Trabecular Bone Score, a Surrogate of Bone Micro-architecture, in the Chronic Kidney Disease Spectrum and in Kidney Transplant Recipients.

Shevroja E, Lamy O, Hans D. Shevroja E, et al. Front Endocrinol (Lausanne). 2018 Sep 24;9:561. doi: 10.3389/fendo.2018.00561. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30319544 Free PMC article. Review.

7

Cohort Profile: The OsteoLaus study.

Shevroja E, Marques-Vidal P, Aubry-Rozier B, Hans G, Rivadeneira F, Lamy O, Hans D. Shevroja E, et al. Int J Epidemiol. 2019 Aug 1;48(4):1046-1047g. doi: 10.1093/ije/dyy276. Int J Epidemiol. 2019. PMID: 30590566 No abstract available.

8

Clinical Performance of the Updated Trabecular Bone Score (TBS) Algorithm, Which Accounts for the Soft Tissue Thickness: The OsteoLaus Study.

Shevroja E, Aubry-Rozier B, Hans G, Gonzalez- Rodriguez E, Stoll D, Lamy O, Hans D. Shevroja E, et al. J Bone Miner Res. 2019 Dec;34(12):2229-2237. doi: 10.1002/jbmr.3851. Epub 2019 Oct 25. J Bone Miner Res. 2019. PMID: 31419331 Free article.

9

Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone.

Koromani F, Oei L, Shevroja E, Trajanoska K, Schoufour J, Muka T, Franco OH, Ikram MA, Zillikens MC, Uitterlinden AG, Krestin GP, Anastassiades T, Josse R, Kaiser SM, Goltzman D, Lentle BC, Prior JC, Leslie WD, McCloskey E, Lamy O, Hans D, Oei EH, Rivadeneira F. Koromani F, et al. Among authors: shevroja e. Diabetes Care. 2020 Jan;43(1):137-144. doi: 10.2337/dc19-0925. Epub 2019 Oct 28. Diabetes Care. 2020. PMID: 31658976 Free PMC article.

10

OsteoLaus: raisons d’être et premiers résultats.

Shevroja E, Hans D, Aubry-Rozier B, Gonzalez-Rodriguez E, Lamy O. Shevroja E, et al. Praxis (Bern 1994). 2020 Jan;109(1):19-22. doi: 10.1024/1661-8157/a003372. Praxis (Bern 1994). 2020. PMID: 31910768 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page